Vyvanse Leak: What Big Pharma Doesn't Want You To Know - OpenSIPS Trunking Solutions

Nov 17, 2023 · a u. s.

Shortage of the new generic version of vyvanse, an adhd medication, is due in part to federal limits on production, according to an industry group representing generic.

Nov 1, 2024 · soon after vyvanse’s patent expired in 2023, applications for generic formulations of lisdexamfetamine dimesylate started flowing into the fda. Read also: Myaci: The Future You Decide – But Are You Making The Right Choice?

There are now 18 approved.